Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Research Scholarships - Master's program

University of British Columbia

$27,000.00

Engineering Bispecific Natural Killer Cells to Target Cancer Metabolic Heterogeneity

FY 2025-26

Summary
Cell-based immunotherapies are a rapidly emerging area of cancer research with a growing commercial and clinical focus. However, treatments are often designed to target specific features of cancer cells, and over time cancer’s genetic instability leads to patients developing resistance, even to treatments they previously responded to. Instead of directing treatment towards predefined cell traits, our project aims to direct the immune system towards unique and evolving features of cancer metabolism. To do so, we plan to use natural killer (NK) cells. NK cells are a type of immune cell, and they express activating and inhibitory receptors which prevent or promote NK cell killing of healthy or infected cells. The objective of this study is to repurpose these receptors to target features on healthy and cancerous cells, generating an NK cell therapy that kills cancer cells and saves healthy cells based on diverse features of cancer cell metabolism. With this project, we hope to develop a new class of immunotherapy that advances our understanding of what cancer needs for long term survival and uses this understanding to direct immune responses and eliminate malignancies.
Program
Master's Award: Canada Graduate Research Scholarships - Master's program
Location
British Columbia, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
573220
Name
Nathani-Sim Maya
Region
British Columbia
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Engineering Bispecific Natural Killer Cells to Target Cancer Metabolic Heterogeneity
Programtype2
Studentship Programs
Orgnameinp2
University of British Columbia
Cihramount2
$27,000
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Research Scholarships - Master's program
Keyworddelim
Cancer Heterogeneity; Cancer Metabolism; Cancer Mutanome; Cellular Engineering; Crispr; Immunoengineering; Immunotherapy; Natural Killer Cells
Abstract
Cell-based immunotherapies are a rapidly emerging area of cancer research with a growing commercial and clinical focus. However, treatments are often designed to target specific features of cancer cells, and over time cancer’s genetic instability leads to patients developing resistance, even to treatments they previously responded to. Instead of directing treatment towards predefined cell traits, our project aims to direct the immune system towards unique and evolving features of cancer metabolism. To do so, we plan to use natural killer (NK) cells. NK cells are a type of immune cell, and they express activating and inhibitory receptors which prevent or promote NK cell killing of healthy or infected cells. The objective of this study is to repurpose these receptors to target features on healthy and cancerous cells, generating an NK cell therapy that kills cancer cells and saves healthy cells based on diverse features of cancer cell metabolism. With this project, we hope to develop a new class of immunotherapy that advances our understanding of what cancer needs for long term survival and uses this understanding to direct immune responses and eliminate malignancies.
Competitiondate
202512
Approvedterm2
1 yr 0 mth
Pinamesdelim
Nathani-Sim, Maya
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $27,000~ $0~